- Austria (Website)
- Czech Republic (Website)
- Denmark (Website)
- Finland (Website)
- France (Website)
- Germany (Website)
- Hungary (Website)
- Italy (Website)
- Ivory Coast
True Direct Quantification of Salmonella Now an AOAC Approved Reality for the Food Industry31 August, 2021
bioMérieux, Inc. company, obtains AOAC® approval for first-ever enrichment-free Quantification of Salmonella in raw meat and poultry with the GENE-UP® QUANT Salmonella assay.
Chicago, IL, August 31, 2021 — Salmonella detection has been a main-stay requirement in the food industry to prevent foodborne illness. While enrichment-based assays for the Presence / Absence detection of food pathogens are still vital to a safe and abundant global food supply, the food industry has longed for an easy to use and reliable diagnostic solution to accurately quantify levels of Salmonella to aid in process and product disposition decisions at the operational level. bioMérieux delivers on this need with breakthrough “real time” Quantitative analysis for Salmonella with the first-ever AOAC approved PCR assay for the enrichment-free quantification of Salmonella in foods. The AOAC Research Institute Performance Tested Methods℠ certification (PTM 061801) is for the true direct quantification of Salmonella is aptly named GENE-UP® QUANT Salmonella.
Accurate quantification of Salmonella is an important tool for food safety and quality professionals to allow for smart decision making, efficient product disposition and re-direction, and appropriate interventions to maximize operational performance and company profits.
“AOAC approval of GENE-UP QUANT Salmonella demonstrates our ongoing commitment to provide the food industry with reliable, robust, and innovative solutions,” says Ron Johnson, Sr. Scientific Advisor bioMérieux, Inc. and former President of AOAC INTERNATIONAL. “We work directly with producers to address their big challenges and solve their most pressing problems.”
Until now, the only AOAC approved solution relied on enrichment-based threshold testing for semi-quantitative understanding of Salmonella levels. “Threshold testing risks inaccurate assessment of the true Salmonella population dynamics when you need a true count,” says Adam Joelsson, Director of Technology & Head of Research & Development at Invisible Sentinel, a bioMérieux company. “GENE-UP QUANT Salmonella allows operations to easily assess a true count, without enrichment, to make confident same-shift data-driven decisions."
Poultry, beef, and pork producers can now take advantage of GENE-UP QUANT Salmonella and the entire suite of animal protein microbiology testing solutions from bioMérieux. This approval adds to a vast portfolio of international validations across the bioMérieux pathogen and quality indicator suite of solutions, and demonstrates a long-standing commitment to robust, reliable, and validated science.
AOAC INTERNATIONAL is a global standardization organization that certifies analytical test methods. The AOAC Performance Tested Methods℠ designation is recognized by the US Department of Agriculture, the Food and Drug Administration, and global regulatory agencies. Visit AOAC’s website to learn more about their certification process and explore our website to learn more about our suite of food safety and quality solutions.
A world leader in the field of in vitro diagnostics for more than 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2019, revenues reached €2.7 billion, with over 90% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
bioMérieux Corporate Industry Head Office:
+33 (0) 668740207